Free shipping on all orders over $ 500

BMS 794833

Cat. No. M1683

All AbMole products are for research use only, cannot be used for human consumption.

BMS 794833 Structure
Size Price Availability Quantity
1mg USD 45  USD45 In stock
5mg USD 95  USD95 In stock
10mg USD 155  USD155 In stock
25mg USD 260  USD260 In stock
50mg USD 460  USD460 In stock
100mg USD 720  USD720 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

BMS-794833 is a potent ATP competitive Met/VEGFR-2 kinase inhibitor and it also inhibits Ron (Met family), Axl and Flt-3 with IC50 values <3 nM. BMS-794833 was selective versus a panel of >200 additional RTKs, non-RTKs and serine/threonine kinases based on biochemical or Ambit binding assays. In cell culture, BMS-794833 inhibited the proliferation of human tumor cell lines containing constitutively activated Met receptor (GTL-16 gastric carcinoma). In vivo, BMS-794833 demonstrated dose-dependent tumor growth inhibition following oral administration in the GTL-16 and L2987 lung carcinoma (Met-insensitive) xenograft models.

Protocol (for reference only)
Cell Experiment
Cell lines gastric cancer cell line (GTL-16)
Preparation method cell proliferation assay
Concentrations IC50 = 39 nM
Incubation time
Animal Experiment
Animal models U87 glioblastoma model
Formulation
Dosages 25mg/kg
Administration
Chemical Information
Molecular Weight 468.84
Formula C23H15ClF2N4O3
CAS Number 1174046-72-0
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Nao Nishida-Aoki, et al. Polypharmacologic Reprogramming of Tumor-Associated Macrophages toward an Inflammatory Phenotype

Related c-Met Products
Zurletrectinib

Zurletrectinib (ICP-723) is a potent tyrosine kinase inhibitor. Zurletrectinib serves as an antineoplastic agent. Zurletrectinib can used for research of TRK-mediated related diseases.

ABN401 

ABN401 is a highly potent and selective ATP-competitive c-MET inhibitor with an IC50 value of 10 nM.

(Z)-Semaxanib

(Z)-Semaxanib is a potent tyrosine kinase inhibitor.

MET kinase-IN-2 

MET kinase-IN-2 is a potent, selective, orally bioavailable MET kinase inhibitor with an IC50 of 7.4 nM.

BMS-817378

BMS-817378 is a potent and selective inhibitor of MET with IC50 of 1.7 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: BMS 794833 supplier, c-Met, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.